Rubric Capital Management LP Chimerix Inc Transaction History

Rubric Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$1.19 - $2.09 $194,285 - $341,223	-163,265 Reduced 2.18%	7,336,735 $9.24 Million
Q4 2022 Feb 10, 2023	BUY	$1.67 - $2.35 $1.46 Million - $2.06 Million	875,000 Added 13.21%	7,500,000 $14 Million
Q3 2022 Nov 14, 2022	SELL	$1.81 - $2.76 $831,883 - $1.27 Million	-459,604 Reduced 6.49%	6,625,000 $12.8 Million
Q2 2022 Aug 15, 2022	BUY	$1.34 - $5.34 $3.06 Million - $12.2 Million	2,284,604 Added 47.6%	7,084,604 $14.7 Million
Q4 2021 Feb 14, 2022	BUY	$5.23 - $7.18 $4.18 Million - $5.74 Million	800,000 Added 20.0%	4,800,000 $30.9 Million
Q3 2021 Nov 12, 2021	BUY	$5.94 - $8.75 $23.8 Million - $35 Million	4,000,000 New	4,000,000 $24.8 Million

37M

52.7K

130K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $77.1M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Rubric Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rubric Capital Management LP with notifications on news.